Author

O. Zimhony

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:proteomics· 3 Organism:human· 2 Research Focus:cell type annotation· 1 Organism:E. coli· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

A. Clark· 1 shared A. F. Carlin· 1 shared A. Mechaly· 1 shared A. Roitburd-Berman· 1 shared A. Schwartz· 1 shared A. Tennenhouse· 1 shared A. Zvi· 1 shared B. A. Croker· 1 shared

Activity by Year

2018-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Clark

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against novel viral variants

E. Makdasi, A. Zvi, R. Alcalay, T. Noy-Porat, E. Peretz, A. Mechaly, Y. Levy, E. Epstein, T. Chitlaru, A. Tennenhouse, M. Aftalion, D. Gur, N. Paran, H. Tamir, O. Zimhony, , R. Rosenfeld

This study evaluates the neutralization potency of four SARS-CoV-2 mAbs against spike mutations and two variants of concern, finding that MD65 and BL6 retain effectiveness against B.1.1.7 and B.1.351.

bioRxiv · Apr 1, 2021Immunology

Multi-Clonal Live SARS-CoV-2 In Vitro Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors

M. Mor, M. Werbner, J. Alter, M. Safra, E. Chomsky, S. Hada-Neeman, K. Polonsky, C. Nowell, A. Clark, A. Roitburd-Berman, N. Ben-Shalom, M. Navon, D. Rafael, H. Sharim, E. Kiner, , N. Freund

This study identifies multi-clonal neutralizing antibodies against SARS-CoV-2 in severe COVID-19 patients and shows their potential for combination therapy.

bioRxiv · Oct 6, 2020Immunology

Expression of a recombinant, 4’-Phosphopantetheinylated, active M. tuberculosis Fatty acid Synthase I in E. coli

S. Baron, Y. Peleg, J. Grunwald, D. Morgenstern, N. Elad, M. Peretz, S. Albeck, Y. Levin, J. T. Welch, K. A. Deweerd, A. Schwartz, Y. Burstein, R. Diskin, Z. Shakked, O. Zimhony

This paper describes the expression and activation of Mtb FAS I in E. coli using AcpS, confirming its biochemical activity and structural properties.

bioRxiv · Aug 28, 2018Microbiology